More specifically, reports showed that loss of DACH1 expression results in increased CRC cell growth, motility, and invasiveness through transforming growth factor β-mediated Epithelial-Mesenchymal Transition (EMT), and downregulation of DACH1 has important therapeutic implications for targeted therapies of CRC (Wang, 2015). Here, DACH1 is linked to colorectal carcinoma.